01 August 2024
Health Care Law Today
FDA: The Effects of Loper on the Regulatory Agenda
The Supreme Court’s decision in June 2024 in Loper Bright Enterprises v. Raimondo and Relentless Inc. v. Department of Commerce to overrule the Chevron doctrine has major implications for every administrative agency, including the U.S. Food & Drug Administration.
